what is the difference between glp-1 and tirzepatide Bridging gap GLP1-receptor agonists cardiovascular outcomes: evidence for the role of | Cardiovascular Diabetology Effects of tirzepatide, a dual

Learn from world-class conversations with leading endocrinologists, metabolic researchers, and healthcare innovators

Overall, these findings underscore the complexity of the molecular interactions with the neural circuitry underlying anxiety and highlight the necessity for a multifaceted approach in the design of anxiolytic treatments

Tesofensine is typically administered orally in capsule form, with daily doses ranging from 0.25 mg to 1 mg

Birkedal recommends starting with GLP-1s and considering surgical weight loss after a few months of medication: Surgery is a life-altering decision

Include waist change and, if possible, composition checks